Results for tag: Hagop Kantarjian Total Items Found: 19

Influence of the ‘Mark Cuban Effect’ on Cancer Drug Prices in the United States: Focus on CML

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 2/9/2023 9:03:23 PM

Will the Trump Administration’s Plan to Reduce Cancer Drug Prices Work?

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 12/19/2018 4:56:54 PM

The Arrival of Generic Imatinib Into the U.S. Market: An Educational Event

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 5/23/2016 11:23:26 AM

Hagop Kantarjian MD on CAR T Cells in Relapsed Refractory ALL

Type of Page:TapVideo
Edit This Item
Tags for this item:
american society of hematology
ash annual meeting
hagop kantarjian
all
car t-cell therapy
oncology
hematology
cancer
asco post

Created: 1/31/2016 9:50:08 AM

Hagop Kantarjian MD on Inotuzumab Ozogamicin Plus Low-Intensity Chemotherapy in ALL

Type of Page:TapVideo
Edit This Item
Tags for this item:
american society of hematology
ash annual meeting
hagop kantarjian
inotuzumab ozogamicin
all
leukemia
hematology
oncology
asco post

Created: 1/31/2016 9:49:29 AM

Hagop Kantarjian MD on Blinatumomab in Precursor B-Cell ALL

Type of Page:TapVideo
Edit This Item
Tags for this item:
american society of hematology
ash annual meeting
hagop kantarjian
all
leukemia
blinatumomab
cancer
oncology
asco post

Created: 1/31/2016 9:48:40 AM

Hagop Kantarjian MD on Treating Philadelphia Chromosome–Positive ALL

Type of Page:TapVideo
Edit This Item
Tags for this item:
american society of hematology
ash annual meeting
hagop kantarjian
all
leukemia
philadelphia chromosome
nilotinib
dasatinib
cancer
asco post

Created: 1/31/2016 9:47:11 AM

James O. Armitage MD and Hagop M. Kantarjian MD on Advances in the Treatment of ALL

Type of Page:TapVideo
Edit This Item
Tags for this item:
James Armitage Hagop Kantarjian
ASH
ALL
blinatumumab
inotuzumab
ponatinib
Ph+ ALL
CAR T-cells

Created: 1/31/2016 9:41:34 AM

The 340B Drug Pricing Program: Background, Concerns, and Solutions

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/29/2016 7:18:46 PM

Chemotherapy Drug Shortages: A Preventable Human Disaster

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/11/2016 11:38:57 AM

Updates on Ruxolitinib from ASCO and ASH 2012, including Long-term Survival Data

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:35:54 PM

Cost of Cancer Drugs: What Price for What Benefit?

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:33:23 PM

We Need Gemtuzumab Available Again to Treat AML

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:32:40 PM

Homoharringtonine/Omacetaxine: The Little Drug that Could

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:30:02 PM

Drug Approvals in Acute Myeloid Leukemia: Can We Do Better?

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:29:08 PM

Does the United States Have the Best Health-Care System in the World?

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:07:01 PM

Relevance of the Hippocratic Oath in the 21st Century

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:04:19 PM

Is Health Care in the United States a Basic Human Right or an Entitlement?

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 4:52:21 PM

Hagop M. Kantarjian, MD, on AML: Safety and Efficacy of Guadecitabine

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Hagop Kantarjian
MD Anderson
AML
acute myeloid leukemia
guadecitabine
hypomethylating agent
treatment-naïve
intensive chemotherapy

Created: 12/24/2015 12:16:33 PM
Order By Item Count
Order Alphabetically